
|Videos|June 5, 2022
Updates in the Medicine Chest
Author(s)Katie Hobbins
In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.
Advertisement
From oral apremilast (Otezla; Amgen Inc) to tapinarof (Dermavant Sciences) and roflumilast (Arcutis Biotherapeutics), James Q. Del Rosso, DO, research director of JDR Dermatology Research in Las Vegas, Nevada and senior vice president of clinical research and strategic development at Advanced Dermatology & Cosmetic Surgery in Maitland, Florida, highlighted updates in the health care professional’s armamentarium for dermatology at the current Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, 2022 in Scottsdale, Arizona.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
4
Topical GX-03 Hits 92.6% EASI-50 at Week 4 in Phase 2 AD Interim
5














